비교리스트

 카트 문의
시장보고서
상품코드
1362427

당뇨병성 족궤양 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 범위 : 궤양 유형, 치료 유형, 감염 중증도, 최종 사용자, 지역별 분석

Diabetic Foot Ulcer Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Coverage: Ulcer Type, Treatment Type, Infection Severity, End User, and Geography
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 231 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 당뇨병성 족궤양 시장은 2022년 74억 7,060만 달러에서 2030년 122억 4,227만 달러에 달할 것으로 예상되며, 2022년에서 2030년까지 6.4%의 CAGR을 나타낼 것으로 예상됩니다.

시장 성장을 가속하는 주요 요인은 당뇨병 및 관련 만성 상처의 높은 유병률과 노인 인구의 급격한 증가입니다. 그러나 고급 상처 치료는 높은 비용으로 인해 시장 성장을 어느 정도 저해하고 있습니다.

당뇨병성 족궤양 시장 시장 기회

당뇨병성 족궤양은 만성 상처의 일종으로, 종종 합병증을 유발하고 외과의사들은 이러한 상처를 관리하는 데 어려움을 겪습니다. 당뇨병성 족궤양과 같은 만성 상처 환자 수가 크게 증가함에 따라 체계적인 치료 접근법의 필요성이 가속화되고 있으며, 효과적인 상처 치료를 위해 증거에 기반한 치료법을 도입하는 것이 권장되고 있습니다. 만성 상처 관리와 관련된 여러 연구와 임상시험을 통해 생물학적 활성 상처 관리 제품이 기존 상처 관리 제품보다 습윤 상처를 더 효과적으로 치유하는 것으로 입증되었습니다. 정부 기관 및 연구 기관의 적극적인 참여는 상처 치료 치료의 발전을 촉진하고 있습니다. 예를 들어, 2021년 6월 호주의 임상 단계 줄기세포 및 재생의료 기업 Cynata Therapeutics Limited는 TekCyte와 당뇨병성 족궤양에 대한 임상시험을 진행하기 위해 라이선스 계약을 체결했습니다. 는 당뇨병성 족궤양 치료를 위해 자사의 중간엽 줄기세포 제품 '사이멜스'에 대한 임상시험을 시작했습니다. 또한 2022년 6월, 스미스앤네퓨는 영국 헐(Hull) 외곽에 첨단 상처 관리 프랜차이즈를 위한 R&D 시설을 신설한다고 발표했습니다. 스미스앤네퓨는 1억 달러 이상을 투자해 세계 최고 수준의 R&D 시설과 유연한 사무실 환경을 구축했습니다. 영국 정부의 보조금도 이 개발을 지원하고 있습니다. 이처럼 각 기업의 연구 활동과 이니셔티브 증가는 시장 성장에 유리한 기회로 작용할 것으로 보입니다.

당뇨병성 족궤양 시장 성장 억제요인

Integra LifeSciences Corporation에 따르면, 당뇨병성 족궤양 치료비용은 미국 의료시스템에 연간 90억-130억 달러에 달하는 막대한 부담을 주고 있습니다. 허더스필드대학이 발표한 자료에 따르면 의료 관련 감염(HCAI), 특히 수술 부위 감염(SSI)의 치료 비용은 영국에서 10억 파운드(-12억 6,000만 달러)에 달하는 것으로 추정됩니다. 또한 호주 당뇨병 협회(Diabetes Australia)에 따르면 당뇨병으로 인한 사지 절단은 약 23,555달러, 수술 후 연간 6,065달러의 추가 비용이 발생하며, 5년 동안 당뇨병으로 인한 절단은 사회적 비용을 제외하고 의료 시스템에 거의 50,000달러에 해당합니다. 입니다. 상처의 면적과 치료의 복잡성도 치료 비용을 좌우합니다.

당뇨병성 족궤양 치료비는 인도, 중국, 한국 등 아시아태평양 국가에서도 높은데, 엘스비어(Elsevier)가 2022년에 발표한 연구에 따르면 중국의 당뇨병성 족궤양 치료비는 절단, 입원, 치료를 포함해 1인당 21,372달러에 달할 전망입니다. 마찬가지로 인도에서는 항생제, 신경장애 치료제, 드레싱 재료, 콜라겐 스커폴드, 성장인자, 음압상처치료, 수술 등을 포함해 1인당 약 19,599달러다. 이처럼, 환급이 가능함에도 불구하고 고급 상처 치료의 고비용은 당뇨병성 족궤양 시장의 세계 성장을 억제하는 주요 요인으로 작용하고 있습니다.

당뇨병성 족궤양 시장 부문별 개요

세계 당뇨병성 족궤양 시장은 치료 유형에 따라 고급 상처 드레싱 재료, 생물학적 제제 및 치료 장비로 분류되며, 2022년에는 고급 상처 치료 드레싱 재료 분야가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 전통적인 방법과 비교할 때 고급 상처 드레싱 재료의 주요 장점은 거즈와 테이프의 사용과 관련이 있습니다. 고급 상처 드레싱의 이러한 구성 요소는 배액 문제가 적고 치유 속도가 빠르며 감염 위험이 낮습니다. 생물학적 제제 부문은 2022-2030년 가장 높은 CAGR을 기록할 것으로 예상됩니다.

세계 당뇨병성 족궤양 시장은 궤양 유형에 따라 신경병증성 궤양, 허혈성 궤양, 신경허혈성 궤양으로 구분됩니다. 신경허혈성 궤양 부문은 2022년에 가장 큰 시장 점유율을 차지할 것으로 예상되며, 2022-2030년간 가장 높은 CAGR을 기록할 것으로 예상됩니다. 신경허혈성 궤양은 주로 발, 발가락, 발등 가장자리, 특히 발에 맞지 않는 신발을 신는 사람의 압박 부위에 발생하는 궤양입니다. 이러한 유형의 상처 관리는 비교적 복잡합니다. 상처는 빠른 치료, 적절한 신발, 오프 로딩, 드레싱 재료 및 감염 치료가 필요합니다. 신경허혈성 궤양은 가장 흔한 당뇨병성 족궤양(DFU)입니다.

세계 당뇨병성 족궤양 시장은 감염의 중증도에 따라 중등도, 경증, 중증으로 분류됩니다. 경증은 2022년에 가장 큰 시장 점유율을 차지하며 예측 기간(2022-2030년) 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다. 세계 당뇨병성 족궤양 시장을 최종 사용자별로 살펴보면, 외래수술센터(ASC), 병원, 재택치료로 나뉩니다. 병원 부문은 2022년에 가장 큰 시장 점유율을 차지할 것으로 예상되며, 2022-2030년간 가장 높은 CAGR을 기록할 것으로 예상됩니다. 병원은 복잡하지만 전문적인 과학 장비를 사용하여 사람들에게 의료 서비스를 제공하는 복잡한 조직입니다. 병원은 현대 의학 문제를 교육받은 직원을 임명합니다. 병원은 만성적이고 치유하기 어려운 상처로 고통받는 환자에게 고급 치료 옵션을 제공합니다. 대부분의 만성 상처 수술은 병원에서 이루어지며, 이는 수술 후 지속적인 환자 관리와 모니터링이 제공되기 때문입니다. 따라서 병원 부문의 성장이 기대되는 이유입니다.

당뇨병성 족궤양 시장 지역별 개요

북미에서 미국은 당뇨병성 족궤양의 가장 큰 시장이며, 이는 주로 미국 내 당뇨병 유병률 증가에 기인합니다. 미국 족부 의학 협회(American Podiatric Medical Association)에 따르면, 미국에서 족궤양이 발생한 당뇨병 환자의 약 14-24%는 절단이 필요한 것으로 나타났습니다. 건강 혁신 프로그램에 따르면, 미국에서는 연간 200만 명이 당뇨병성 족궤양을 앓고 있습니다. 또한 2022년 NCBI에서 발표된 연구에 따르면 미국 당뇨병 환자의 -5%가 족부궤양을 앓고 있으며, 1%는 절단에 이르게 됩니다.

이 지역의 노인 인구 증가도 시장 성장을 가속하고 있으며, 2022년 발표된 미국 보건복지부 고령화 대책국의 보고서에 따르면 2020년 미국에는 65세 이상 노인 인구가 5,570만 명에 달할 것으로 예상했습니다. 이 노인층은 전체 인구의 17%, 즉 미국인 6명 중 1명을 차지합니다. 어반 인스티튜트(Urban Institute, 워싱턴 DC 소재 싱크탱크)의 추정에 따르면, 65세 이상 인구는 향후 40년 동안 두 배로 증가해 2040년에는 미국에서 8,000만 명에 달할 것으로 예상했습니다. 또한 2020년에는 당뇨병이 65세 이상 성인의 주요 만성질환 중 하나가 될 것으로 예상됩니다. 최근 몇 년동안 여러 합작 투자, 이니셔티브 및 협력이 북미의 당뇨병 성 족궤양 시장 확장을 가속화하는 데 기여했습니다. 예를 들어, 2020년 미국의 6개 연구기관은 미국 국립보건원(NIH)의 지원을 받아 당뇨병성 족궤양 연구를 위한 최초의 다기관 네트워크를 출범시켰습니다. 또한, 캐나다에서는 당뇨병성 족부 합병증 예방을 위한 Diabetic Foot Canada 프로그램이 시작되었습니다. 이처럼 높은 당뇨병 유병률과 노인 인구 증가는 이 지역 시장 성장을 가속할 것으로 보입니다.

당뇨병성 족궤양 시장 보고서를 작성할 때 참고한 주요 1차 및 2차 정보에는 세계은행(World Bank) 데이터, 국가보건서비스(NHS), 미국 식품의약국(FDA), 유럽의약품청(EMA), 세계보건기구(WHO) 등이 포함됩니다.

목차

제1장 서론

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 당뇨병성 족궤양 시장 구도

  • PEST 분석
    • 세계의 PEST 분석

제5장 당뇨병성 족궤양 시장 - 주요 산업 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 영향 분석

제6장 당뇨병성 족궤양 시장 : 세계 시장 분석

  • 당뇨병성 족궤양 시장 매출, 2022년-2030년

제7장 세계의 당뇨병성 족궤양 시장 - 2030년까지 매출과 예측-치료 유형별

  • 세계의 당뇨병성 족궤양 시장 매출 점유율, 치료 유형별, 2022년·2030년(%)
  • 첨단 창상관리 드레싱
  • 생물제제
  • 치료 디바이스

제8장 세계의 당뇨병성 족궤양 시장 : 2030년까지 매출과 예측 : 궤양 유형별

  • 세계의 당뇨병성 족궤양 시장 : 2022년·2030년 궤양 유형별 판매량 점유율(%)
  • 신경장애성 궤양
  • 허혈성 궤양
  • 신경허혈성 궤양

제9장 세계의 당뇨병성 족궤양 시장 : 2030년까지 매출과 예측 : 감염 중증도별

  • 세계의 당뇨병성 족궤양 시장 : 2022년 및 2030년 감염 중증도 별 판매량 점유율(%)
  • 경증, 중등증, 중증

제10장 세계의 당뇨병성 족궤양 시장 - 2030년까지 매출과 예측-최종사용자별

  • 세계의 당뇨병성 족궤양 시장 : 최종사용자별 매출 점유율(2022년·2030년)
  • 병원
  • 외래수술센터(ASC)
  • 재택치료

제11장 당뇨병성 족궤양 시장 - 지역별 분석

  • 북미
    • 멕시코
  • 유럽
    • 기타 유럽
  • 아시아태평양
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 기타 중동 및 아프리카
  • 중남미
    • 기타 중남미

제12장 당뇨병성 족궤양 시장 업계 상황

  • 세계의 당뇨병성 족궤양 시장 성장 전략
  • 무기적 성장 전략
  • 유기적 성장 전략

제13장 당뇨병성 족궤양 시장 - 주요 기업 개요

  • Convatec Group Plc
  • 3M Co
  • Coloplast AS
  • Smith & Nephew Plc
  • B. Braun SE
  • Molnlycke Health Care AB
  • MiMedx Group Inc
  • URGO MEDICAL Australia Pty Ltd
  • Medline Industries LP
  • Organogenesis Inc.

제14장 부록

LSH 23.10.24

The global diabetic foot ulcer market is expected to reach US$ 12,242.77 million in 2030 from US$ 7,470.60 million in 2022. The market is estimated to grow with a CAGR of 6.4% from 2022 to 2030.

The key factors driving the market's growth are high prevalence of diabetes and related chronic wounds and the surge in geriatric population. However, high cost of advanced wound care treatments is hampering the market's growth to a certain extent.

Market Opportunities of Diabetic Foot Ulcer Market

Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. With the significant growth in the patient pool suffering from chronic wounds, such as diabetic foot ulcers, the need for a systematic treatment approach has accelerated, encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wound management have demonstrated that bioactive wound care products help heal moist wounds more effectively than traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in wound care treatments. For instance, in June 2021, Cynata Therapeutics Limited, an Australian clinical-stage stem cell and regenerative medicine company, signed a license agreement with TekCyte to advance clinical trials in diabetic foot ulcers. In December 2021, a clinical trial on its Cymerus mesenchymal stem cell product used to treat diabetic foot ulcers was launched by Cynata Therapeutics. Similarly, in June 2022, Smith+Nephew announced a new R&D facility for its advanced wound management franchise on the outskirts of Hull, UK. Smith+Nephew invested over US$ 100 million to create a world-class R&D and flexible office environment. A grant from the UK government also supports the development. Thus, the growing research activities and initiative by players will provide lucrative opportunities for the market growth.

Factors Hampering Diabetic Foot Ulcer Market

According to Integra LifeSciences Corporation, the cost of diabetic foot ulcers treatment has an enormous burden on the US healthcare system-ranging between US$ 9 and US$ 13 billion annually. According to the data published by the University of Huddersfield, the cost of treating health care associated infections (HCAIs), particularly surgical site infections (SSIs), has been estimated to represent £1 billion (~US$ 1.26 billion) in the UK. Further, according to Diabetes Australia, diabetes-associated limb amputation costs nearly US$ 23,555, with an additional annual expense of US$ 6,065 post surgery. Over five years, diabetes-related amputation amounts to almost US$ 50,000 for the health system, excluding social costs. The area of a wound and the complexity of procedures also determine the cost of the treatment.

The cost of diabetic foot ulcer treatment is also high in Asia Pacific countries such as India, China, and South Korea. According to a study published in 2022 by Elsevier, the cost of diabetic foot ulcer treatment is ~US$ 21,372/patient in China covering amputations, hospitalizations and medical treatments. Similarly, in India, the cost is around ~US$ 19,599/patient including antibiotics, neuropathic drugs, dressings, collagen scaffolds, growth factors, negative pressure wound therapy, and surgery. Thus, the high cost of advanced wound care treatments, despite the availability of reimbursements, is a key factor restraining the diabetic foot ulcer market growth globally.

Diabetic Foot Ulcer Market: Segmental Overview

The global diabetic foot ulcer market, by treatment type, is segmented into advanced wound care dressings, biologics, and therapy device. The advanced wound care dressings segment held the largest market share in 2022. Major benefits of advanced wound care dressings over traditional methods are associated with the use of gauze and tape. These components of advanced wound care dressings aid in faster healing with fewer issues regarding drainage, and lower risk of accompanying infection. The biologics segment is anticipated to register the highest CAGR during 2022-2030.

The global diabetic foot ulcer market, by ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers. The neuro-ischemic ulcers segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030. Neuro-ischemia predominately leads to the development of ulcers on the foot, toes, and dorsum margins, especially on pressure sites occurring among people using poorly fitting shoes. The management of such types of wounds is comparatively complex. The wound requires prompt care, appropriate footwear, offloading, dressings, and infection treatment. Neuro-ischemic ulcers are the most common diabetic foot ulcers (DFUs).

The global diabetic foot ulcer market, by infection severity, is segmented into moderate, mild, and severe. The mild segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR during the forecast period (2022-2030). The global diabetic foot ulcer market, by end user, is segmented into ambulatory surgical centers, hospitals, and home care. The hospital segment held the largest market share in 2022 and the same segment is anticipated to register the highest CAGR from 2022 to 2030. Hospitals are complex organizations that provide healthcare services to people using complex but specialized scientific equipment. Hospitals appoint trained staff members that are educated in the problems of modern medical science. Hospitals offer advanced treatment options for patients suffering from chronic and hard-to-heal wounds. Most of the surgeries on chronic wounds are performed in hospitals, owing to the continuous patient care and monitoring offered in these facilities post-surgery. Thus, the hospital segment is expected to grow.

Diabetic Foot Ulcer Market: Geographical Overview

In North America, the US is the largest market for diabetic foot ulcers, primarily driven by the increasing prevalence of diabetes in the country. As per the American Podiatric Medical Association, in the US, nearly 14-24% of patients with diabetes who develop foot ulcers require an amputation. According to the Health Innovation Program, ~2 million people in America develop a diabetic foot ulcer annually. Furthermore, according to a study published in NCBI in 2022, ~5% of patients in the US with diabetes mellitus develop foot ulcers, and 1% end up with an amputation.

The growing geriatric population in the region also boosts the market growth. According to the Administration on Aging (US Department of Health and Human Services) report published in 2022, there were 55.7 million people aged 65 and above in 2020 in the US. The old age group represents 17% of the population, i.e., 1 in every 6 Americans. As per estimates by the Urban Institute (Washington, DC-based think tank), the number of people aged 65 and older will double over the next 40 years, reaching 80 million in 2040 in the US. Additionally, In 2020, diabetes is regarded as among the leading chronic conditions among adults aged 65 and above. In recent years, several joint ventures, initiatives, and collaborations contributed in accelerating the diabetic foot ulcers market expansion in North America. For instance, in 2020, six research institutions in the US launched the first-ever multicenter network funded by the National Institutes of Health to study diabetic foot ulcers in the US. Additionally, the Diabetic Foot Canada program was launched in Canada to prevent diabetic foot complications. Thus, the high prevalence of diabetes and the increasing geriatric population will drive the market growth in the region.

A few of the major primary and secondary sources referred to while preparing the report on the diabetic foot ulcer market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the diabetic foot ulcer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global diabetic foot ulcer market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the diabetic foot ulcer market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Diabetic Foot Ulcer Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Diabetic Foot Ulcer Market - Key Industry Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
    • 5.1.2 Surge in Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Advanced Wound Care Treatments
  • 5.3 Market Opportunities
    • 5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
  • 5.4 Future Trends
    • 5.4.1 Use of 3D Printing in Wound Care Management
  • 5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market - Global Market Analysis

  • 6.1 Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

  • 7.1 Overview
  • 7.2 Global Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • 7.3 Advanced Wound Care Dressings
    • 7.3.1 Overview
    • 7.3.2 Advanced Wound Care Dressings: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Alginate Dressings
      • 7.3.3.1 Overview
      • 7.3.3.2 Alginate Dressings: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Hydrofiber Dressings
      • 7.3.4.1 Overview
      • 7.3.4.2 Hydrofiber Dressings: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Foam Dressings
      • 7.3.5.1 Overview
      • 7.3.5.2 Foam Dressings: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Collagen Dressing
      • 7.3.6.1 Overview
      • 7.3.6.2 Collagen Dressing: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.7 Film Dressing
      • 7.3.7.1 Overview
      • 7.3.7.2 Film Dressing: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.8 Other Dressings
      • 7.3.8.1 Overview
      • 7.3.8.2 Other Dressing: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biologics
    • 7.4.1 Overview
    • 7.4.2 Biologics: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 Growth Factors
      • 7.4.3.1 Overview
      • 7.4.3.2 Growth Factors: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Skin Graft
      • 7.4.4.1 Overview
      • 7.4.4.2 Skin Graft: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Therapy Device
    • 7.5.1 Overview
    • 7.5.2 Therapy Device: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.3 Negative Pressure Wound Therapy
      • 7.5.3.1 Overview
      • 7.5.3.2 Negative Pressure Wound Therapy: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.4 Ultrasound Therapy
      • 7.5.4.1 Overview
      • 7.5.4.2 Ultrasound Therapy: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type

  • 8.1 Overview
  • 8.2 Global Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
  • 8.3 Neuropathic Ulcers
    • 8.3.1 Overview
    • 8.3.2 Neuropathic Ulcers: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ischemic Ulcers
    • 8.4.1 Overview
    • 8.4.2 Ischemic Ulcers: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neuro-ischemic Ulcers
    • 8.5.1 Overview
    • 8.5.2 Neuro-ischemic Ulcers: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

  • 9.1 Overview
  • 9.2 Global Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
  • 9.3 Mild, Moderate, and Severe
    • 9.3.1 Overview
    • 9.3.2 Mild: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Moderate: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.4 Severe: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

  • 10.1 Overview
  • 10.2 Global Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Centers: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Home Care
    • 10.5.1 Overview
    • 10.5.2 Home Care: Global Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market - Geographical Analysis

  • 11.1 North America Diabetic Foot Ulcer Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.1.2.1 North America Diabetic Foot Ulcer Market, by Ulcer Type
      • 11.1.2.2 North America Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.2.2.1 North America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.2.2.2 North America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.2.2.3 North America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
      • 11.1.2.3 North America Diabetic Foot Ulcer Market, by Infection Severity
      • 11.1.2.4 North America Diabetic Foot Ulcer Market, by End User
      • 11.1.2.5 North America Diabetic Foot Ulcer Market, by Country
      • 11.1.2.6 US
        • 11.1.2.6.1 US Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.6.2 US Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.2.6.3 US Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.2.6.3.1 US: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.2.6.3.2 US: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.2.6.3.3 US: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.2.6.4 US Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.2.6.5 US Diabetic Foot Ulcer Market, by End User
      • 11.1.2.7 Canada
        • 11.1.2.7.1 Canada Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.7.2 Canada Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.2.7.3 Canada Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.2.7.3.1 Canada: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.2.7.3.2 Canada: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.2.7.3.3 Canada: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.2.7.4 Canada Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.2.7.5 Canada Diabetic Foot Ulcer Market, by End User
      • 11.1.2.8 Mexico
        • 11.1.2.8.1 Mexico Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.2.8.2 Mexico Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.2.8.3 Mexico Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.2.8.3.1 Mexico: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.2.8.3.2 Mexico: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.2.8.3.3 Mexico: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.2.8.4 Mexico Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.2.8.5 Mexico Diabetic Foot Ulcer Market, by End User
  • 11.2 Europe Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.2.2.1 Europe Diabetic Foot Ulcer Market, by Ulcer Type
      • 11.2.2.2 Europe Diabetic Foot Ulcer Market, by Treatment Type
        • 11.2.2.2.1 Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.2.2.2.2 Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.2.2.2.3 Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
      • 11.2.2.3 Europe Diabetic Foot Ulcer Market, by Infection Severity
      • 11.2.2.4 Europe Diabetic Foot Ulcer Market, by End User
      • 11.2.2.5 Europe Diabetic Foot Ulcer Market by Country
      • 11.2.2.6 Germany
        • 11.2.2.6.1 Germany Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.6.2 Germany Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.2.2.6.3 Germany Diabetic Foot Ulcer Market, by Treatment Type
        • 11.2.2.6.3.1 Germany: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.2.2.6.3.2 Germany: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.2.2.6.3.3 Germany: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.2.2.6.4 Germany Diabetic Foot Ulcer Market, by Infection Severity
        • 11.2.2.6.5 Germany Diabetic Foot Ulcer Market, by End User
      • 11.2.2.7 UK
        • 11.2.2.7.1 UK Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.7.2 UK Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.2.2.7.3 UK Diabetic Foot Ulcer Market, by Treatment Type
        • 11.2.2.7.3.1 UK: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.2.2.7.3.2 UK: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.2.2.7.3.3 UK: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.2.2.7.4 UK Diabetic Foot Ulcer Market, by Infection Severity
        • 11.2.2.7.5 UK Diabetic Foot Ulcer Market, by End User
      • 11.2.2.8 France
        • 11.2.2.8.1 France Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.8.2 France Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.2.2.8.3 France Diabetic Foot Ulcer Market, by Treatment Type
        • 11.2.2.8.3.1 France: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.2.2.8.3.2 France: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.2.2.8.3.3 France: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.2.2.8.4 France Diabetic Foot Ulcer Market, by Infection Severity
        • 11.2.2.8.5 France Diabetic Foot Ulcer Market, by End User
      • 11.2.2.9 Italy
        • 11.2.2.9.1 Italy Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.9.2 Italy Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.2.2.9.3 Italy Diabetic Foot Ulcer Market, by Treatment Type
        • 11.2.2.9.3.1 Italy: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.2.2.9.3.2 Italy: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.2.2.9.3.3 Italy: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.2.2.9.4 Italy Diabetic Foot Ulcer Market, by Infection Severity
        • 11.2.2.9.5 Italy Diabetic Foot Ulcer Market, by End User
      • 11.2.2.10 Spain
        • 11.2.2.10.1 Spain Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.10.2 Spain Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.2.2.10.3 Spain Diabetic Foot Ulcer Market, by Treatment Type
        • 11.2.2.10.3.1 Spain: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.2.2.10.3.2 Spain: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.2.2.10.3.3 Spain: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.2.2.10.4 Spain Diabetic Foot Ulcer Market, by Infection Severity
        • 11.2.2.10.5 Spain Diabetic Foot Ulcer Market, by End User
      • 11.2.2.11 Rest of Europe
        • 11.2.2.11.1 Rest of Europe Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.2.11.2 Rest of Europe Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.2.2.11.3 Rest of Europe Diabetic Foot Ulcer Market, by Treatment Type
        • 11.2.2.11.3.1 Rest of Europe: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.2.2.11.3.2 Rest of Europe: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.2.2.11.3.3 Rest of Europe: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.2.2.11.4 Rest of Europe Diabetic Foot Ulcer Market, by Infection Severity
        • 11.2.2.11.5 Rest of Europe Diabetic Foot Ulcer Market, by End User
  • 11.3 Asia Pacific Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.3.2.1 Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
      • 11.3.2.2 Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
        • 11.3.2.2.1 Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.3.2.2.2 Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.3.2.2.3 Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
      • 11.3.2.3 Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
      • 11.3.2.4 Asia Pacific Diabetic Foot Ulcer Market, by End User
      • 11.3.2.5 Asia Pacific Diabetic Foot Ulcer Market by Country
      • 11.3.2.6 China
        • 11.3.2.6.1 China Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.6.2 China Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.3.2.6.3 China Diabetic Foot Ulcer Market, by Treatment Type
        • 11.3.2.6.3.1 China: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.3.2.6.3.2 China: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.3.2.6.3.3 China: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.3.2.6.4 China Diabetic Foot Ulcer Market, by Infection Severity
        • 11.3.2.6.5 China Diabetic Foot Ulcer Market, by End User
      • 11.3.2.7 Japan
        • 11.3.2.7.1 Japan Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.7.2 Japan Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.3.2.7.3 Japan Diabetic Foot Ulcer Market, by Treatment Type
        • 11.3.2.7.3.1 Japan: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.3.2.7.3.2 Japan: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.3.2.7.3.3 Japan: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.3.2.7.4 Japan Diabetic Foot Ulcer Market, by Infection Severity
        • 11.3.2.7.5 Japan Diabetic Foot Ulcer Market, by End User
      • 11.3.2.8 India
        • 11.3.2.8.1 India Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.8.2 India Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.3.2.8.3 India Diabetic Foot Ulcer Market, by Treatment Type
        • 11.3.2.8.3.1 India: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.3.2.8.3.2 India: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.3.2.8.3.3 India: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.3.2.8.4 India Diabetic Foot Ulcer Market, by Infection Severity
        • 11.3.2.8.5 India Diabetic Foot Ulcer Market, by End User
      • 11.3.2.9 Australia
        • 11.3.2.9.1 Australia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.9.2 Australia Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.3.2.9.3 Australia Diabetic Foot Ulcer Market, by Treatment Type
        • 11.3.2.9.3.1 Australia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.3.2.9.3.2 Australia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.3.2.9.3.3 Australia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.3.2.9.4 Australia Diabetic Foot Ulcer Market, by Infection Severity
        • 11.3.2.9.5 Australia Diabetic Foot Ulcer Market, by End User
      • 11.3.2.10 South Korea
        • 11.3.2.10.1 South Korea Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.10.2 South Korea Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.3.2.10.3 South Korea Diabetic Foot Ulcer Market, by Treatment Type
        • 11.3.2.10.3.1 South Korea: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.3.2.10.3.2 South Korea: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.3.2.10.3.3 South Korea: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.3.2.10.4 South Korea Diabetic Foot Ulcer Market, by Infection Severity
        • 11.3.2.10.5 South Korea Diabetic Foot Ulcer Market, by End User
      • 11.3.2.11 Rest of Asia Pacific
        • 11.3.2.11.1 Rest of Asia Pacific Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.2.11.2 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.3.2.11.3 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Treatment Type
        • 11.3.2.11.3.1 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.3.2.11.3.2 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.3.2.11.3.3 Rest of Asia Pacific: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.3.2.11.4 Rest of Asia Pacific Diabetic Foot Ulcer Market, by Infection Severity
        • 11.3.2.11.5 Rest of Asia Pacific Diabetic Foot Ulcer Market, by End User
  • 11.4 Middle East & Africa Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa Diabetic Foot Ulcer Market, by Ulcer Type
    • 11.4.4 Middle East & Africa Diabetic Foot Ulcer Market, by Treatment Type
      • 11.4.4.1 Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
      • 11.4.4.2 Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
      • 11.4.4.3 Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    • 11.4.5 Middle East & Africa Diabetic Foot Ulcer Market, by Infection Severity
    • 11.4.6 Middle East & Africa Diabetic Foot Ulcer Market, by End User
      • 11.4.6.1 Middle East & Africa Diabetic Foot Ulcer Market by Country
      • 11.4.6.2 UAE
        • 11.4.6.2.1 UAE Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.2.2 UAE Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.4.6.2.3 UAE Diabetic Foot Ulcer Market, by Treatment Type
        • 11.4.6.2.3.1 UAE: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.4.6.2.3.2 UAE: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.4.6.2.3.3 UAE: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.4.6.2.4 UAE Diabetic Foot Ulcer Market, by Infection Severity
        • 11.4.6.2.5 UAE Diabetic Foot Ulcer Market, by End User
      • 11.4.6.3 Saudi Arabia
        • 11.4.6.3.1 Saudi Arabia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.3.2 Saudi Arabia Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.4.6.3.3 Saudi Arabia Diabetic Foot Ulcer Market, by Treatment Type
        • 11.4.6.3.3.1 Saudi Arabia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.4.6.3.3.2 Saudi Arabia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.4.6.3.3.3 Saudi Arabia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.4.6.3.4 Saudi Arabia Diabetic Foot Ulcer Market, by Infection Severity
        • 11.4.6.3.5 Saudi Arabia Diabetic Foot Ulcer Market, by End User
      • 11.4.6.4 South Africa
        • 11.4.6.4.1 South Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.4.2 South Africa Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.4.6.4.3 South Africa Diabetic Foot Ulcer Market, by Treatment Type
        • 11.4.6.4.3.1 South Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.4.6.4.3.2 South Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.4.6.4.3.3 South Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.4.6.4.4 South Africa Diabetic Foot Ulcer Market, by Infection Severity
        • 11.4.6.4.5 South Africa Diabetic Foot Ulcer Market, by End User
      • 11.4.6.5 Rest of Middle East & Africa
        • 11.4.6.5.1 Overview
        • 11.4.6.5.2 Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.5.3 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.4.6.5.4 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Treatment Type
        • 11.4.6.5.4.1 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.4.6.5.4.2 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.4.6.5.4.3 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.4.6.5.5 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Infection Severity
        • 11.4.6.5.6 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by End User
  • 11.5 South & Central America Diabetic Foot Ulcer Market, Revenue And Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
      • 11.5.2.1 South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
      • 11.5.2.2 South & Central America Diabetic Foot Ulcer Market, by Treatment Type
        • 11.5.2.2.1 South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.5.2.2.2 South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.5.2.2.3 South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
      • 11.5.2.3 South & Central America Diabetic Foot Ulcer Market, by Infection Severity
      • 11.5.2.4 South & Central America Diabetic Foot Ulcer Market, by End User
      • 11.5.2.5 South & Central America Diabetic Foot Ulcer Market by Country
      • 11.5.2.6 Brazil
        • 11.5.2.6.1 Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.2.6.2 Brazil Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.5.2.6.3 Brazil Diabetic Foot Ulcer Market, by Treatment Type
        • 11.5.2.6.3.1 Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.5.2.6.3.2 Brazil: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.5.2.6.3.3 Brazil: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.5.2.6.4 Brazil Diabetic Foot Ulcer Market, by Infection Severity
        • 11.5.2.6.5 Brazil Diabetic Foot Ulcer Market, by End User
      • 11.5.2.7 Argentina
        • 11.5.2.7.1 Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.2.7.2 Argentina Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.5.2.7.3 Argentina Diabetic Foot Ulcer Market, by Treatment Type
        • 11.5.2.7.3.1 Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.5.2.7.3.2 Argentina: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.5.2.7.3.3 Argentina: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.5.2.7.4 Argentina Diabetic Foot Ulcer Market, by Infection Severity
        • 11.5.2.7.5 Argentina Diabetic Foot Ulcer Market, by End User
      • 11.5.2.8 Rest of South & Central America
        • 11.5.2.8.1 Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.2.8.2 Rest of South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.5.2.8.3 Rest of South & Central America Diabetic Foot Ulcer Market, by Treatment Type
        • 11.5.2.8.3.1 Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.5.2.8.3.2 Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.5.2.8.3.3 Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.5.2.8.4 Rest of South & Central America Diabetic Foot Ulcer Market, by Infection Severity
        • 11.5.2.8.5 Rest of South & Central America Diabetic Foot Ulcer Market, by End User

12. Diabetic Foot Ulcer Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Diabetic Foot Ulcer Market - Key Company Profiles

  • 13.1 Convatec Group Plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 3M Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Coloplast AS
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Smith & Nephew Plc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 B. Braun SE
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Molnlycke Health Care AB
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 MiMedx Group Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 URGO MEDICAL Australia Pty Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Medline Industries LP
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Organogenesis Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제